Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Venture Life ( (GB:VLG) ) has provided an update.
Venture Life Group PLC announced that its Non-Executive Chairman, Paul McGreevy, has purchased 66,776 ordinary shares at a volume-weighted average price of 59.90 pence per share. This acquisition increases McGreevy’s total holdings to 963,825 shares, representing approximately 0.75% of the company’s issued share capital. This move may indicate confidence in the company’s strategic direction and could potentially impact investor perceptions positively.
More about Venture Life
Venture Life is an international consumer self-care company headquartered in the UK, focusing on commercializing products for the global self-care market. Its product portfolio includes Balance Activ for women’s intimate healthcare, Earol® for ENT care, and Lift and Glucogel for energy and glucose management. These products are available through health & beauty stores, pharmacies, grocery multiples, and e-commerce channels, and are sold globally. In the UK, Ireland, and the USA, they are supplied directly to retailers, while in other regions, they are distributed by international partners.
Average Trading Volume: 356,974
Technical Sentiment Signal: Buy
Current Market Cap: £77.47M
Learn more about VLG stock on TipRanks’ Stock Analysis page.